Keratinocyte Growth Factor Modified Messenger RNA Accelerating Cell Proliferation and Migration of Keratinocytes
October 2018
in “
Nucleic Acid Therapeutics
”
Studysummary This study suggests that transfection with modified KGF-mRNA enhances keratinocyte reepithelialization in wound therapy by temporarily increasing growth factor expression without affecting nuclear DNA.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document from December 2018 explored the use of modified Keratinocyte Growth Factor (KGF) messenger RNA (mRNA) to stimulate keratinocyte proliferation and migration, which are essential for wound healing. The in vitro study showed that transfection with KGF-mRNA led to increased KGF protein release and improved reepithelialization in scratch assays, suggesting that mRNA therapy could be a promising approach for enhancing wound healing. The study highlighted the benefits of mRNA therapy, such as its temporary effect and avoidance of risks associated with gene therapy. While the study demonstrated positive results in cell cultures, it did not involve human subjects and did not specify the number of cells used. The authors recommended further research to validate the use of KGF-mRNA in wound therapy.
